SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, has expanded its international footprint with the launch of Sri Lanka's first robotic cardiac surgery program at Kings Hospital Colombo, powered by its SSi Mantra 3.0 surgical robotic system. The program began with a robotic-assisted left internal mammary artery takedown performed by company founder and Chairman Dr. Sudhir Srivastava alongside Kings Hospital cardiothoracic surgeon Dr. Rajitha DeSilva. According to the company, the hospital completed more than 25 robotic procedures within the first three weeks, demonstrating rapid adoption of the technology.
The launch matters because it represents a tangible step in SS Innovations' strategy to make robotic surgery affordable and accessible in emerging markets. The company reported 224 cumulative SSi Mantra installations across 12 countries at the end of the second quarter of 2026, and the Sri Lanka program adds to that growing installed base. More importantly, quarterly revenue increased 39% year over year to $13.9 million, while robotic procedures rose 143% to 2,528. That procedure growth signals increased utilization of installed systems, which is critical because higher utilization creates potential opportunities for recurring revenue from surgical instruments and consumables. As more hospitals adopt the SSi Mantra platform, the recurring revenue stream becomes a larger and more predictable part of the business model.
SS Innovations is also pursuing broader market access, with U.S. FDA clearance targeted for the first quarter of 2027 and European CE marking targeted for the end of 2026. Those regulatory milestones, if achieved, would open two of the world's largest and most lucrative surgical markets, significantly expanding the company's addressable population and competitive positioning. For investors, the Sri Lanka launch is a proof point that the company can execute on its international expansion strategy while simultaneously advancing toward regulatory approvals in high-income markets. The full article is available at https://nnw.fm/DJ6dI.
SS Innovations develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. Its product range includes the proprietary SSi Mantra surgical robotic system and its comprehensive suite of SSi Mudra surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. Headquartered in India, SS Innovations is a U.S. company focused on expanding the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. More information is available at SSInnovations.com, and the latest news and updates relating to SSII are available in the company's newsroom at https://nnw.fm/SSII.
The announcement was distributed through NetworkNewsWire, a specialized communications platform focused on financial news and content distribution for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio at IBN that delivers access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries, along with editorial syndication to 5,000+ outlets and social media distribution via IBN to millions of social media followers. Full terms of use and disclaimers are available at https://www.NetworkNewsWire.com/Disclaimer.
